Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinoma：A Multi-center, Single-arm Study

NCT04888429 is registered in ClinicalTrials.gov with Qian Chu as lead sponsor.

NCT NCT04888429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04888429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinoma：A Multi-center, Single-arm Study
Lead sponsor
Qian Chu
Phase
Phase 2
Overall status
Completed
Start date
July 19, 2021
Completion date
June 30, 2025
Enrollment
17 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

sarcomatoid carcinoma of lung